Heartflow, Inc. filings document a Nasdaq-listed Delaware medical technology company focused on AI software for coronary artery disease. Its recent 8-K reports furnish operating results, investor presentations and Regulation FD disclosures, while also recording capital-structure events tied to its completed initial public offering and repayment and termination of a credit agreement.
The company’s proxy materials cover annual meeting matters, director elections, auditor ratification and stockholder voting mechanics. As an emerging growth company, Heartflow’s filings also identify governance, exchange listing, financial reporting and public-company status disclosure areas relevant to a commercial-stage medical technology issuer.
Heartflow, Inc. (HTFL) received a notice that officer Vikram Verghese intends to sell 4,593 shares of common stock under Rule 144 through Fidelity Brokerage Services LLC. These shares were acquired via a stock option exercise on June 10, 2024 for cash.
The filing lists an aggregate market value of $230,743.50 for the 4,593 shares and states that 86,953,627 shares of common stock were outstanding as of September 14, 2026. It also discloses several prior sales of HTFL common stock by Verghese during the past three months.
Heartflow, Inc. (HTFL) received a Rule 144 notice indicating that John C M Farquhar plans to sell 3,890 shares of Heartflow common stock through Fidelity Brokerage Services LLC. The shares relate to a stock option exercise
Heartflow, Inc. (HTFL) is the issuer for a notice under Rule 144 covering planned sales of common stock for the account of officer Vikram Verghese through Fidelity Brokerage Services LLC. The notice lists stock option exercises for 1,733 shares dated December 26, 2024 and 27,981 shares dated June 10, 2024, all to be paid in cash.
The filing also reports that, during the prior three months, Vikram Verghese sold Heartflow common stock in three transactions: 5,876 shares on September 2, 2026 for $297,325.60, 27,540 shares on September 3, 2026 for $1,368,471.99, and 6,640 shares on September 8, 2026 for $332,211.70.
Heartflow, Inc. (HTFL) reported that its Chief Financial Officer, Vikram Verghese, sold 6,640 shares of common stock on September 8, 2026 in an open-market transaction at a weighted average price of $50.0319 per share, with trades executed between $50.00 and $50.12.
After this sale, he held 214,503 shares of Heartflow common stock directly. The sale was effected pursuant to a Rule 10b5-1 trading plan adopted on June 4, 2026.
Heartflow, Inc. (HTFL) is the issuer for a Rule 144 notice filed on behalf of John C. M. Farquhar, identified as an officer/director, covering planned sales of common stock. The filing lists 35,010 shares of common stock to be sold, following their acquisition through a stock option exercise on June 25, 2024, with Fidelity Brokerage Services LLC as the broker. It also details multiple prior sales of Heartflow common stock by the same person during the past three months.
Heartflow, Inc. (HTFL) received a notice under Rule 144 that Vikram Verghese plans to sell 6,640 shares of common stock, expected to be acquired through a stock option exercise on December 26, 2024. The filing lists 86,953,627 shares outstanding of common stock as of September 8, 2026.
The notice also reports prior Rule 144 sales by Vikram Verghese of 5,876 shares on September 2, 2026 and 27,540 shares on September 3, 2026, through Fidelity Brokerage Services LLC.
Heartflow, Inc. (HTFL) disclosed that its Chief Financial Officer, Vikram Verghese, sold a total of 33,416 shares of common stock in open-market transactions on September 2–3, 2026. All reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted on June 4, 2026.
On September 3, 2026, he sold 27,540 shares at a weighted average price of about $49.69 per share, from individual trades between $48.22 and $50.80. On September 2, 2026, he sold 5,876 shares at $50.60 per share in a separate open-market transaction.
Heartflow, Inc. (HTFL) has a notice from officer Vikram Verghese to sell shares of its common stock under Rule 144. The notice covers up to 27,540 shares of HTFL common stock, with an aggregate market value of $1,368,471.99, to be sold through Fidelity Brokerage Services LLC on NASDAQ.
The filing states that Heartflow had 86,953,627 shares of common stock outstanding as of September 3, 2026. It also notes that Verghese sold 5,876 shares of common stock for $297,325.60 on September 2, 2026, which are included in the recent-activity disclosure required by Rule 144.
Heartflow, Inc. (HTFL) received a Rule 144 notice indicating that officer Vikram Verghese plans to sell 5,876 shares of common stock through Fidelity Brokerage Services LLC. The shares relate to restricted stock vesting awards acquired on May 6, 2026, August 6, 2026, and August 7, 2026, with an indicated aggregate market value of $297,325.60 as of September 2, 2026.
Heartflow, Inc. (HTFL) reported that its Chief Executive Officer and director, John C.M. Farquhar, sold 27,230 shares of Common Stock on August 21, 2026 at a price of $50.00 per share in an open-market or private transaction. After this sale, he held 360,814 shares directly. The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on September 12, 2025.